InterLeukin

Today, we honor and celebrate the Philippines 126th Independence Day (Araw ng Kalayaan).On this day in 1898, the country declared independence, ending over 300 years under Spanish rule. Happy Independence Day, Philippines!

READY? SET? TEST! Biomarkers are objective medical signs (as opposed to symptoms reported by the patient) used to measure the presence or progress of disease, or the effects of treatment. Your health may benefit from biomarkers acting as early warning systems. Biomarkers allow for better understanding disease processes and the ways in which drugs work to combat disease. With this understanding, illness can be prevented before it manifests or is diagnosed early. Biomarkers may enable more accurate, secure, and economical healthcare delivery, which would ultimately lead to better health outcomes by personalizing disease prevention and management. Get in touch with us to learn more about how InterLeukin can support the testing services your medical facility offers. Source: National Institutes of Health (NIH)

𝗠𝗮𝘆 𝗶𝘀 𝗠𝗲𝗻𝘁𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵 Mental Health is a state of mental well-being that enables people to cope with the stresses of life, realize their abilities, learn well and work well, and contribute to their community. Individuals who are exposed to poverty, violence, disability and inequality – are at higher risk of developing a mental health condition which can cause difficulties in all aspects of life, including relationships with family, friends and community. And having a mental health condition increases the risk of suicide and experiencing human rights violations. It is important to know that speaking about mental health is a strength, never a weakness. It should not be seen as negative and there is nothing to be a shame of. This is a fight for mental health, are you in? Source: World Health Organization (WHO) #MentalHealthAwarenessMonth #MentalHealth #BreaktheStigmaPromoteKindness

𝐂𝐚𝐥𝐥𝐢𝐧𝐠 𝐚𝐥𝐥 𝐈𝐧𝐭𝐞𝐫𝐧𝐬𝐡𝐢𝐩 𝐒𝐞𝐞𝐤𝐞𝐫𝐬! We got you! InterLeukin offers internship program ideal for undergraduates in their senior year and fresh graduates. This is a 3-to-6-month training program where you will be given tasks and KPIs to achieve depending on the department you are applying for. Additionally, you may request to be trained in another department besides your assigned department. Be part of our team, send your CV/Resume now at people@interleukin.co #BePartofInterLeukin

From the Brain to the Muscles, Every Nerve Matters Neurological Diseases are diseases of the central and peripheral nervous system. Knowing about neurological diseases is essential for improving diagnosis, treatment, and support for individuals living with these conditions, as well as for advancing research and public health efforts aimed at preventing and managing these disorders. Source: World Health Organization (WHO) Know more about how you can get the test with InterLeukin! #Neuroscience #Neurology #Diagnostics #Healthawareness #Healthtechnology

Celebrating 3 years of InterLeukin! Here's to many more years of innovation, growth, and positive impact in the healthcare industry. Thank you for being a part of our journey. Cheers to advancing digital transformation in healthcare distribution and procurement!🎉🥂

Know before it's too late: Recognizing Early Signs Living with a chronic and progressive disease like Parkinson Disease can be challenging. Here are Ten (10) symptoms that may be early signs of Parkinson’s disease. If you or someone you know experiences one or more of these symptoms, seeking medical advice promptly is advisable. Know that early detection and intervention can lead to a better management of the condition and improved quality of life. Reach out to us to find more how InterLeukin can help your medical facility in providing diagnostic test for PD. Source: Parkinson's Foundation #Parkinsons #ParkinsonsAwarenessMonth #Plan4PD #Neuroscience #Diagnostics

Parkinson disease (PD) is a brain condition that primarily affects movement. Its symptoms begin slowly and worsen with time, which can affect the quality of life an individual has. As of today, there is no cure for this disease because the underlying cause is still not completely understood. Let us find out what PD affects, who is most at risk, factors that trigger it and how to treat it if there is no cure. Reach out to us to find more how InterLeukin can help in providing diagnostic test for PD.   Source: World Health Organization (WHO)   #Parkinsons #Neuroscience #Diagnostics

Parkinson disease (PD) is a brain condition that causes problems with movement, mental health, sleep, pain and other health issues. This disease gets worse over time. There is no cure, but therapies and medicines can reduce symptoms. Common symptoms include tremors, painful muscle contractions and difficulty speaking. Parkinson disease results in high rates of disability and the need for care. Many people with PD also develop dementia. The disease usually occurs in older people, but younger people can also be affected. Men are affected more often than women. The cause of PD is unknown but people with a family history of the disease have a higher risk. Exposure to air pollution, pesticides and solvents may increase risk. The prevalence of PD has doubled in the past 25 years. Global estimates in 2019 showed over 8.5 million individuals with PD. Current estimates suggest that, in 2019, PD resulted in 5.8 million disability adjusted life years (DALYs), an increase of 81% since 2000, and caused 329 000 deaths, an increase of over 100% since 2000. People with PD are often subject to stigma and discrimination, including unjust discrimination within the workplace and lack of opportunities to engage and participate in their communities. People with PD require accessible health services for general healthcare needs like the rest of the population, including medicine access, promotive and preventive services and prompt diagnosis, treatment and care. A common barrier is created by healthcare providers’ inadequate knowledge and understanding of PD and myths that PD is a contagious illness or a normal part of aging. Today, InterLeukin is advocating the early diagnosis of PD as we bring specialty diagnostics in the Philippines to different healthcare institutions for easy testing access to lessen the burden of every patient and its family members. Source: World Health Organization (WHO) #Parkinsons #specialtydiagnostics #neurosciences

To all our partners, customers and everyone who support the vision of InterLeukin to provide a better healthy healthcare procurement - from the bottom of our hearts, we THANK YOU for providing us the opportunity to serve you! HAPPY NEW YEAR!!!